Eli Lilly and Company Director of Business Development Salary
The average Eli Lilly and Company Director of Business Development earns an estimated $209,944 annually, which includes an estimated base salary of $160,197 with a $49,747 bonus. Eli Lilly and Company's Director of Business Development compensation is $43,642 more than the US average for a Director of Business Development. Director of Business Development salaries at Eli Lilly and Company can range from $73,000 - $390,000.
The Business Development Department at Eli Lilly and Company earns $3,016 more on average than the IT Department.
Last updated 3 months ago.
- $160,197
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Eli Lilly and Company
Directors of Business Development earn $2,506 more than Directors of Business Development.
Compensation at Eli Lilly and Company by Department
The Business Development Department averages $3,016 more than the IT Department, and $2,785 less than the Marketing Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Eli Lilly and Company reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Eli Lilly and Company reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Eli Lilly and Company Rate Their Compensation
The majority of Directors of Business Development at Eli Lilly and Company believe they're compensated fairly. 100% of Directors of Business Development at Eli Lilly and Company say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Eli Lilly and Company
